← Open Payments lookup

AMELIA KELLEY: Open Payments

NPI 1780068056 · MERIDIAN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$7,926 in 104 payments from 10 companies in 2025. Trend: 2023 $7,191 · 2024 $19,088 · 2025 $7,926

Speaker / faculty: $6,200Food & beverage: $1,424Travel & lodging: $302
CompanyPaymentsAmount
ABBVIE INC.36$6,949
E.R. Squibb & Sons, L.L.C.21$191
Otsuka America Pharmaceutical, Inc.13$178
Teva Pharmaceuticals USA, Inc.10$175
Lundbeck LLC10$168
Axsome Therapeutics, Inc.4$80
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$71
Neurocrine BioSciences, Inc.3$52
Vanda Pharmaceuticals Inc.1$33
Janssen Pharmaceuticals, Inc2$30

Products named: VRAYLAR, COBENFY, REXULTI, UZEDY, ABILIFY MAINTENA, Auvelity, ABILIFY ASIMTUFII, CAPLYTA.

Industry payments across MS — which companies pay providers there.